While most mainstream media describe GLP-1 as a "satiety hormone", This comparison is similar to calling the internet a messaging app According to the Patel & Niazi (2025) review, emerging research suggests that the strength of GLP-1 receptor signalling lies in mitochondrial health and autophagy
In oncology, GLP-1R-targeted nanoplatforms enable highly specific delivery of cytotoxic agents to receptor-expressing tumors, minimizing off-target toxicity while addressing chemoresistance
Commonly prescribed GLP-1 receptor agonists available in the UK include: Semaglutide (Ozempic, Rybelsus - licensed for type 2 diabetes
Focus on stabilizing your weight, optimizing nutrition, and giving your body the 12-18 months it needs for full recovery
Yagyu, H
Semaglutide and tirzepatide are not right for everyone, particularly if you have a personal or family history of the following conditions: You or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
